High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer-Reference-Cited by-同舟云学术

High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer

Published:2016-05-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Farquhar Cindy¹,Marjoribanks Jane¹,Lethaby Anne¹,Azhar Maimoona²

Affiliation:

1. University of Auckland; Department of Obstetrics and Gynaecology; FMHS Park Road Grafton Auckland New Zealand 1003

2. Royal College of Surgeons in Ireland; Department of Surgery; 123 St. Stephen's Green Dublin 2 Ireland

Publisher

Wiley

Subject

Pharmacology (medical)

Reference71 articles.

1. Quality of life in the Anglo-Celtic randomised trial of high dose adjuvant chemotherapy;Forbes;Breast Cancer Research and Treatment,2001

2. Conventional adjuvant chemotherapy versus single-cycle autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomised trial;Leonard;Journal of the National Cancer Institute,2004

3. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable Stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082);Hurd;Journal of the National Cancer Institute Monographs,1995

4. Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of cancer and leukemia group B protocol 9082;Marks;International Journal of Radiation Oncology Biology Physics,2010

5. Quality of life among patients with stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy;Peppercorn;Cancer,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discrepancies in breast cancer guideline recommendations despite similar Cochrane systematic review conclusions;Journal of Evidence-Based Medicine;2024-03

2. High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial;npj Breast Cancer;2023-09-09

3. The three horizons model applied to medical science;Postgraduate Medicine;2022-09-14

4. Highs and Lows of Research;The Oxford Handbook of Research Ethics;2022-03-18

5. Treating Metastatic Brain Cancers With Stem Cells;Frontiers in Molecular Neuroscience;2021-11-24